Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An excessive rate of cardiac death is a well-known feature of renal failure. Coronary heart disease is frequent and the possibility has been raised that the natural history of the coronary plaque is different in uraemic patients. We assessed the morphology of coronary arteries in patients with end-stage renal failure and compared them with coronary arteries of matched non-uraemic control patients. METHODS: Fifty-four cases were identified at autopsy who met the inclusion criteria: cases, end-stage renal disease (n=27); controls, non-renal patients with coronary artery disease (n=27). At autopsy all three coronary arteries were prepared at corresponding sites for investigations: (i) qualitative analysis (after Stary), (ii) quantitative measurements of intima and media thickness (by planimetry), (iii) immunohistochemical analysis of the coronary plaques and (iv) X-ray diffraction of selected calcified plaques. RESULTS: Qualitative analysis of the coronary arteries showed significantly more calcified plaques of coronary arteries in patients with end-stage renal failure. Plaques of non-uraemic patients were mostly fibroatheromatous. Media thickness of coronary arteries was significantly higher in uraemic patients (187+/-53 microm vs 135+/-29 microm in controls) and intima thickness tended to be higher (158+/-38 microm vs 142+/-31 microm) but this difference was not statistically significant. Plaque area (4.09+/-1. 50 mm(2) vs 4.39+/-0.88 mm(2)) was comparable in both groups. Lumen area, however, was significantly lower in end-stage renal patients. Immunohistochemical analysis of the cellular infiltrate in coronary arteries showed no major differences in these advanced plaques of uraemic and non-uraemic subjects. CONCLUSION: Coronary plaques in patients with end-stage renal failure are characterized by increased media thickness and marked calcification. In contrast to the previous opinion the most marked difference compared to non-uraemic controls does not concern the size, but the composition of the plaque. Deposition of calcium within the plaques may contribute to the high complication rate in uraemic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis
Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,776
Braun, J., Oldendorf, M., Moshage, W., Heidler, R., Zeitler, E., & Luft, F. C. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90363-7 · Cited by 794
Report on Management of Renal Failure in Europe, XXIV, 1993
Valderrabano, F., Jones, E. H. P., & Mallick, N. P. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.supp5.1 · Cited by 699
Achenbach, S., Moshage, W., Ropers, D., Nossen, J., & Daniel, W. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392702 · Cited by 382
Arterial calcification and pathology in uremic patients undergoing dialysis
Ibels, L. S., Alfrey, A. C., Huffer, W. E., Craswell, P. W., Anderson, J. T., & Weil, R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)91118-5 · Cited by 297
Dialysis-associated ischemic heart disease: Insights from coronary angiography
Rostand, S. G., Kirk, K. A., & Rutsky, E. A. (1984) · Kidney International · doi:10.1038/ki.1984.70 · Cited by 247
Composition and classification of human atherosclerotic lesions
Stary, H. C. (1992) · Virchows Archiv A Pathological Anatomy and Histopathology · doi:10.1007/bf01660974 · Cited by 202
Changes of Vascular Architecture Independent of Blood Pressure in Experimental Uremia
Amann, K., Neusüss, R., Ritz, E., Irzyniec, T., Wiest, G., & Mall, G. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00248-a · Cited by 153
Self-citation
Cited by
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Moe, S., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000414 · Cited by 1,993
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
Chertow, G. M., Burke, S. K., Raggi, P., & for the Treat to Goal Working Group (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00434.x · Cited by 1,462
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
GANESH, S. K., STACK, A. G., LEVIN, N. W., HULBERT-SHEARON, T., & PORT, F. K. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102131 · Cited by 1,204
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000102971.85504.7c · Cited by 1,144
Chronic Kidney Disease and Coronary Artery Disease
Sarnak, M. J., Amann, K., Bangalore, S., Cavalcante, J. L., Charytan, D. M., Craig, J. C., Gill, J. S., Hlatky, M. A., Jardine, A. G., Landmesser, U., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1017 · Cited by 741
Self-citationMedial vascular calcification revisited: review and perspectives
Lanzer, P., Boehm, M., Sorribas, V., Thiriet, M., Janzen, J., Zeller, T., St Hilaire, C., & Shanahan, C. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu163 · Cited by 737
Oh, J., Wunsch, R., Turzer, M., Bahner, M., Raggi, P., Querfeld, U., Mehls, O., & Schaefer, F. (2002) · Circulation · doi:10.1161/01.cir.0000020222.63035.c0 · Cited by 722
Vascular Calcification Mechanisms
Giachelli, C. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145894.57533.c4 · Cited by 583
Premature cardiovascular disease in chronic renal failure
Baigent, C., Burbury, K., & Wheeler, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02456-9 · Cited by 581
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
Stenvinkel, P., Carrero, J. J. A. A., Axelsson, J., Lindholm, B., Heimbu[Combining Diaeresis]rger, O., & Massy, Z. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 561
Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2004) · Circulation Research · doi:10.1161/01.res.0000141775.67189.98 · Cited by 502
The emerging role of phosphate in vascular calcification
Giachelli, C. M. (2009) · Kidney International · doi:10.1038/ki.2008.644 · Cited by 493
The severe cardiorenal syndrome: ‘Guyton revisited’
Bongartz, L. G., Cramer, M. J., Doevendans, P. A., Joles, J. A., & Braam, B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi020 · Cited by 460
Vascular calcification in chronic kidney disease
Goodman, W. G., London, G., Amann, K., Block, G. A., Giachelli, C., Hruska, K. A., Ketteler, M., Levin, A., Massy, Z., McCarron, D. A., et al. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.005 · Cited by 417
Self-citationWizemann, V., Tong, L., Satayathum, S., Disney, A., Akiba, T., Fissell, R. B., Kerr, P. G., Young, E. W., & Robinson, B. M. (2010) · Kidney International · doi:10.1038/ki.2009.477 · Cited by 408
Underrepresentation of Renal Disease in Randomized Controlled Trials of Cardiovascular Disease
Coca, S. G., Krumholz, H. M., Garg, A. X., & Parikh, C. R. (2006) · JAMA · doi:10.1001/jama.296.11.1377 · Cited by 408
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Amann, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02120508 · Cited by 385
Self-citationMoe, S. M., Reslerova, M., Ketteler, M., O'Neill, K., Duan, D., Koczman, J., Westenfeld, R., Jahnen-Dechent, W., & Chen, N. X. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00333.x · Cited by 366
Cardiovascular complications in chronic kidney disease
Sarnak, M. J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00372-x · Cited by 347
Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., & Budoff, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.298 · Cited by 311
Aikawa, E., Aikawa, M., Libby, P., Figueiredo, J.-L., Rusanescu, G., Iwamoto, Y., Fukuda, D., Kohler, R. H., Shi, G.-P., Jaffer, F. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.827972 · Cited by 310
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
Valdivielso, J. M., Rodríguez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., & Ortiz, A. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312705 · Cited by 305
The heart and vascular system in dialysis
Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 303
Self-citationInflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease
Silverstein, D. M. (2009) · Pediatric Nephrology · doi:10.1007/s00467-008-1046-0 · Cited by 300
Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin
Giachelli, C. M., Speer, M. Y., Li, X., Rajachar, R. M., & Yang, H. (2005) · Circulation Research · doi:10.1161/01.res.0000161997.24797.c0 · Cited by 291
Chronic Kidney Disease–Mineral-Bone Disorder: A New Paradigm
Moe, S. M., Drüeke, T., Lameire, N., & Eknoyan, G. (2007) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.10.005 · Cited by 287
Litwin, M., Wu[Combining Diaeresis]hl, E., Jourdan, C., Trelewicz, J., Niemirska, A., Fahr, K., Jobs, K., Grenda, R., Wawer, Z. T., Rajszys, P., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110932 · Cited by 272
Toussaint, N. D., Lau, K. K., Strauss, B. J., Polkinghorne, K. R., & Kerr, P. G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm660 · Cited by 258
Pathogenesis of vascular calcification in chronic kidney disease
Cozzolino, M., Brancaccio, D., Gallieni, M., & Slatopolsky, E. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00421.x · Cited by 240
Düsing, P., Zietzer, A., Goody, P. R., Hosen, M. R., Kurts, C., Nickenig, G., & Jansen, F. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02037-7 · Cited by 224
Vascular Calcification: Pathophysiology and Risk Factors
Chen, N. X., & Moe, S. M. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0265-8 · Cited by 207
Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice
Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203
COZZOLINO, M., DUSSO, A. S., & SLATOPOLSKY, E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12112511 · Cited by 188
The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045048.71975.fc · Cited by 167
Self-citationLevin, A., & Li, Y. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00651.x · Cited by 173
“In comparison with nonuremic patients, ESRD patients have greater calcified transformation of plaques but do not have greater extension of the plaque or a greater number of early lesions [20].”
BackgroundChronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice
Bro, S., Bentzon, J. F., Falk, E., Andersen, C. B., Olgaard, K., & Nielsen, L. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088024.72216.2e · Cited by 170
Turgut, F., Kanbay, M., Metin, M. R., Uz, E., Akcay, A., & Covic, A. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9410-3 · Cited by 167
“Coronary plaques are different in uremia [7], and the IMT is profoundly abnormal compared to no-renal matched controls [8], due to the direct effects of uremia, as shown by studies of children on dialysis [9].”
BackgroundChronic Kidney Disease as a Coronary Artery Disease Risk Equivalent
Briasoulis, A., & Bakris, G. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0340-4 · Cited by 152
Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?
Wilund, K. R. (2007) · Clinical Science · doi:10.1042/cs20060368 · Cited by 138
Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease
Erickson, K. F., Japa, S., Owens, D. K., Chertow, G. M., Garber, A. M., & Goldhaber-Fiebert, J. D. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.034 · Cited by 74
Kono, K., Fujii, H., Nakai, K., Goto, S., Shite, J., Hirata, K.-I., Fukagawa, M., & Nishi, S. (2012) · Kidney International · doi:10.1038/ki.2012.118 · Cited by 66
Metadata
- Authors
- Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G., & Amann, K.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02-01
- Volume
- 15
- Issue
- 2
- Pages
- 218-223
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2134132325
- Cited by
- 628
- References
- 16
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.